Log In
Print
BCIQ
Print
Print this Print this
 

Breast Cancer Gene Expression Ratio Test, H/I ratio (HOXB13:IL17BR)

  Manage Alerts
Collapse Summary General Information
Company Quest Diagnostics Inc.
DescriptionTest to predict the risk of disease recurrence in women with estrogen receptor-positive, lymph node-negative breast cancer
Molecular Target Not applicable
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsPredict benefit of prolonged endocrine therapy in estrogen receptor-positive breast cancer patients
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today